-
Some injectable drugs to sidestep Medicare negotiations until 2030s
Injectable versions of some widely used cancer drugs may be excluded from the new Medicare price negotiations until the 2030s, Reuters reported July 28. -
Happy 100th birthday to chemotherapy pioneer
Cancer care pioneer Irwin Krakoff, MD, celebrated his 100th birthday July 20. -
5 oncology leaders on the work they're proudest of
Cancer treatment is more than its therapies, and hospitals are utilizing a number of medical practices, social determinants of health programs and technologies to make cancer care more accessible and effective. -
Can science make cancer destroy itself?
Cancer's aggressive tendency to spread, grow and further deteriorate the bodies that house it, may be reversible making it become its own aggressor, attacking and destroying itself, according to research published July 26 in Nature. -
New York cancer center seeks PR firm to boost DEI image after years of lawsuits
Roswell Park Comprehensive Cancer Center in Buffalo, N.Y., is seeking out a public relations firm to help boost its diversity, equity and inclusion presence and efforts after previously refusing to release a DEI report and being accused of racism, according to Buffalo News. -
80% of Texas pancreatic cancer patients don't get life-prolonging surgery: Study
Almost 80 percent of pancreatic cancer patients in Texas are not getting the level of standard-of-care surgery that could prolong survival, according to a study published May 23 in the Journal of Surgical Oncology. -
$400M Moffitt Cancer Center surgery hospital opening soon in Florida
A $400 million inpatient surgical hospital will open July 31 at the Moffitt Cancer Center in Tampa, Fla., according to a July 21 WUSF news release. -
9 cancer studies to know
Here are nine cancer studies and research you might have missed: -
What keeps oncology leaders up at night
Oncology leaders face many challenges in the field, and three in particular are top of mind: timeliness, treatment options and innovations. -
Cancer drug shortages wreak havoc on clinical trials
Many agencies are delaying cancer trials and research due to cancer drug shortages, which may have a long-term effect on treatments, CNN reported July 20. -
Longtime Temple leader, pioneering medical oncologist dies at 83
Richard Creech, MD, a pioneering medical oncologist, researcher and longtime leader, died July 1 of cancer at 83, The Philadelphia Inquirer reported July 19. -
Tennessee Oncology to build $120M cancer center, headquarters
Nashville-based Tennessee Oncology announced plans to build a $120 million medical center in downtown Nashville, according to a July 19 report in The Tennessean. -
Another breast cancer vaccine shows promise in early trial
A breast cancer vaccine has shown promise in a phase 1 trial spearheaded by researchers at University of Washington's Cancer Vaccine Institute and is preparing to move to phase 2, a July 17 Fred Hutchinson Cancer Center news release said. -
$16.2M gift to boost brain cancer research at MD Anderson
Houston-based University of Texas MD Anderson Cancer Center has received a gift of $16.25 million for brain cancer and neuroscience research, according to a July 18 news release shared with Becker's. -
Robotic tool offers 'significant' advance in lung cancer diagnostics at Baptist Health
Clinicians are using robot-assisted technology to diagnose and treat lung cancer in a same-day procedure at Baptist Health Paducah (Ky.) and four other system hospitals. -
Meet one of the cancer leaders pioneering cellular therapy treatments
Michael Postow, MD, chief of melanoma service at Memorial Sloan Kettering Cancer Center in New York City, picked oncology because it was a place where he could make the biggest impact. -
Barbara Ann Karmanos Cancer Institute taps chief development officer
Detroit-based Barbara Ann Karmanos Cancer Institute named Arnold D'Ambrosio chief development officer, effective July 10. -
Top 4 cancer centers in North Dakota, per US News
Here are the top four cancer hospitals in North Dakota, according to U.S. News & World Report rankings. -
WHO warns of sweetener that may cause cancer; FDA disagrees
A World Health Organization analysis classified non-sugar sweetener aspartame as possibly carcinogenic to humans, but the FDA disagrees with the assessment. -
Fred Hutch Cancer Center: 4 new ways to approach patient pain management
Seattle-based Fred Hutchinson Cancer Center is working to close a gap in communications between physicians and patients about their pain.
Page 29 of 50